Home›Belatacept›Belatacept + Mycophenolate Mofetil

Does Belatacept Interact with Mycophenolate Mofetil?

Belatacept and Mycophenolate Mofetil have a moderate drug interaction according to U.S. FDA drug labeling data. Monitor for need to adjust MMF dosage when switching between cyclosporine and belatacept, as cyclosporine decreases MPA exposure while belatacept does not. May require higher MMF dosage after switching to cyclosporine or lower dosage after switching from cyclosporine to belatacept. The mechanism involves cyclosporine decreases mycophenolic acid exposure by preventing enterohepatic recirculation; belatacept does not have this effect. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Belatacept Class
Selective T Cell Costimulation Blocker
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Belatacept and Mycophenolate Mofetil occurs because cyclosporine decreases mycophenolic acid exposure by preventing enterohepatic recirculation; belatacept does not have this effect. Clinically, this means monitor for need to adjust mmf dosage when switching between cyclosporine and belatacept, as cyclosporine decreases mpa exposure while belatacept does not. may require higher mmf dosage after switching to cyclosporine or lower dosage after switching from cyclosporine to belatacept. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Belatacept and your doctor is considering prescribing Mycophenolate Mofetil (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Belatacept(Nulojix)+💊 Mycophenolate Mofetil(Cellcept)

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Selective T Cell Costimulation Blocker
Drug B class
—
Source
NLP:belatacept

What this means in plain English

Monitor for need to adjust MMF dosage when switching between cyclosporine and belatacept, as cyclosporine decreases MPA exposure while belatacept does not. May require higher MMF dosage after switching to cyclosporine or lower dosage after switching from cyclosporine to belatacept.

About Belatacept and Mycophenolate Mofetil

Belatacept is a Selective T Cell Costimulation Blocker. You may recognize them by the brand names Nulojix and Cellcept. Belatacept is given by intravenous (IV) infusion, whereas Mycophenolate Mofetil is taken by mouth. Both Belatacept and Mycophenolate Mofetil carry an FDA boxed warning — the agency's most serious safety designation.

What the FDA label says

"Cyclosporine decreases mycophenolic acid exposure by preventing enterohepatic recirculation; belatacept does not have this effect"

📖 Source: NLP:belatacept

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Belatacept and Mycophenolate Mofetil against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.